Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2025 09:15 ET | Source: Research and Markets

China Leads Therapeutic Access with 74 Approved Immuno-Oncology Agents

Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Immuno-oncology (2025)" has been added to ResearchAndMarkets.com's offering. The latest report delves into the dynamic...
November 27, 2025 08:17 ET | Source: Research and Markets

C-Met-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of c-Met-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 05, 2025 04:06 ET | Source: Research and Markets

Oncology Adjuvants Research Report 2025: Market to Reach $2.17 Billion by 2029, Driven by Precision-, Immuno-Oncology, AI-Driven Models and Nanotechnology-Enhanced Adjuvants - Forecast to 2034

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Oncology Adjuvants Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The oncology adjuvants market size has grown...
October 15, 2025 07:44 ET | Source: Research and Markets

Non-Small Cell Lung Cancer Analysis Report 2025: Market Dominated by Roche, AstraZeneca, Merck, and Novartis, Fueled by Immuno-Oncology, Targeted Therapies, and Strategic Pipeline Collaborations

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
September 02, 2025 07:16 ET | Source: Research and Markets

Non-Small Cell Lung Cancer (NSCLC) Market Growth Trends and Business Opportunities 2025-2035 by Region

Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been...
April 28, 2025 10:21 ET | Source: Research and Markets

Targeted Therapies for Non-Small Cell Lung Cancer (NSCLC): Addressing Ten Actionable Genomic Alterations in a Competitive Market

Dublin, April 28, 2025 (GLOBE NEWSWIRE) -- The "Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)" report has been added to ResearchAndMarkets.com's offering. This report...
April 08, 2022 13:00 ET | Source: Kura Oncology, Inc.

Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergence of Resistance to Osimertinib in Non-Small Cell Lung Cancer

– Late-breaking presentation at AACR demonstrates potential to significantly delay onset of drug resistance to EGFR-targeted therapies through combination with a farnesyl transferase inhibitor – –...
November 06, 2020 02:34 ET | Source: DelveInsight Business Research LLP

Correction: Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade

Los Angeles, USA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade The Non-Small Cell Lung Cancer Pipeline...
November 02, 2020 10:17 ET | Source: DelveInsight Business Research LLP

Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade

Los Angeles, USA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade The Non-Small Cell Lung Cancer Pipeline...
January 08, 2016 07:30 ET | Source: Transparency Market Research

Non-Small Cell Lung Cancer Therapeutics Market Expected to Reach US$ 15.1 Bn in 2023: Transparency Market Research

Albany, NY, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research has published a new market report titled, “Non Small Cell Lung Cancer Therapeutics Market - Global Industry Analysis,...